Clariant AG reports CHF 918M in Q1 sales, down 2% year-on-year, citing geopolitical tensions and strategic portfolio adjustments.
Clariant AG posted a 2% decline in first-quarter sales to CHF 918M in local currencies, driven by lower Catalyst volumes due to the Middle East conflict and portfolio pruning in Care Chemicals. The company’s EBITDA margin before exceptional items fell 130 basis points to 17.5%.
The drop follows a period of mixed performance, with prior quarters showing modest growth amid supply chain challenges. Comparable periods saw similar volatility in chemical demand, particularly in industrial segments.
No immediate market reaction was disclosed in the release.